Neoadjuvant chemotherapy (NACT) selection for advanced stage ovarian cancer (AOC) at a comprehensive cancer center.

被引：0
|
作者：
Mueller, Jennifer J.
Alvi, Farah Abbas
El Haraki, Amr S.
Eriksson, Ane Gerda
Zhou, Qin
Iasonos, Alexia
O'Cearbhaill, Roisin Eilish
Chi, Dennis
Abu-Rustum, Nadeem
Zivanovic, Oliver
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[3] Weill Cornell Med Coll, New York, NY USA
[4] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e16579
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16579
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The role of neoadjuvant chemotherapy in patients with advanced (stage IIIC) epithelial ovarian cancer
    Skof, Erik
    Merlo, Sebastjan
    Pilko, Gasper
    Kobal, Borut
    RADIOLOGY AND ONCOLOGY, 2016, 50 (03) : 341 - 346
  • [32] THE ROLE OF NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH ADVANCED (STAGE IIIC) EPITHELIAL OVARIAN CANCER
    Skof, E.
    Cerar, O.
    Bebar, S.
    Djurisic, A.
    Merlo, S.
    Vakselj, A.
    Kobal, B.
    Cvjeticanin, B.
    Barbic, M.
    Meglic, L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1494 - 1494
  • [33] Current Status and Controversies in Neoadjuvant Chemotherapy for Advanced Stage Ovarian Cancer: A Review
    Li, Jiaxi
    Zhao, Jitong
    Liao, Shuying
    Bian, Ce
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2023, 50 (11):
  • [34] An increased ratio of cytotoxic to suppressive T cells after neoadjuvant chemotherapy (NACT) is prognostic in advanced ovarian cancer
    Khairallah, A.
    Auguste, A.
    Leary, A.
    Genestie, C.
    Pautier, P.
    Michels, J.
    Morice, P.
    Bentivegna, E.
    Maulard, A.
    Drusch, F.
    Mesnage, S.
    Gouy, S.
    ANNALS OF ONCOLOGY, 2017, 28
  • [35] Factors associated with delivery of neoadjuvant chemotherapy in women with advanced stage ovarian cancer
    Hinchcliff, Emily
    Melamed, Alexander
    Bregar, Amy
    Diver, Elisabeth
    Clemmer, Joel
    Del Carmen, Marcela
    Schorge, John O.
    Rauh-Hain, J. Alejandro
    GYNECOLOGIC ONCOLOGY, 2018, 148 (01) : 168 - 173
  • [36] Neoadjuvant chemotherapy in advanced ovarian cancer: optimal patient selection and response evaluation
    Cho, Jae Hyun
    Kim, Seik
    Song, Yong Sang
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (06)
  • [37] Determine The Role of Locoregionally Advanced Oral Cancer (LAOC) Neoadjuvant Chemotherapy(NACT)
    Patil, Shilpa C.
    Nashte, Abhijeet
    Bagwan, M. B.
    Kapale, R. J.
    JOURNAL OF PIONEERING MEDICAL SCIENCES, 2023, 12 (02): : 58 - 60
  • [38] Intraperitoneal chemotherapy after interval debulking surgery for advanced-stage ovarian cancer: Feasibility and outcomes at a comprehensive cancer center
    Mueller, Jennifer J.
    Kelly, Amelia
    Zhou, Qin
    Iasonos, Alexia
    Roche, Kara Long
    Sonoda, Yukio
    O'Cearbhaill, Roisin E.
    Zivanovic, Oliver
    Chi, Dennis S.
    Gardner, Ginger J.
    GYNECOLOGIC ONCOLOGY, 2016, 143 (03) : 496 - 503
  • [39] Revisiting the role of interval cytoreductive surgery (ICS) following neoadjuvant chemotherapy (NACT) for patients with advanced stage epithelial ovarian cancer; a multicenter database analysis
    Nasioudis, Dimitrios
    Latif, Nawar
    Ko, Emily
    Gysler, Stefan
    Cory, Lori
    Simpkins, Fiona
    Kim, Sarah
    Cliby, William
    Li, Robert Giuntoli
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A199 - A199
  • [40] Neoadjuvant Chemotherapy or Primary Surgery in Advanced Ovarian Cancer
    Chua, Terence C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (24): : 2371 - 2371
12345